pirtobrutinib
eli lilly
['pirto', 'lymsm', 'pirtobrutinib']
#eha2022 | anthony mato presented the phase i/ii bruin study, investigating btki pirtobrutinib in pts with advanced b-cell malignancies with &gt;2 prior therapies. no dlts were reported and maximum tolerated dose was not reached. promising efficacy was shown #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm